The short answer: Amyloidosis is a group of diseases in which abnormally folded proteins build up in tissues and damage organs. When these proteins accumulate in the kidneys, they can damage the tiny blood-filtering units, causing protein to leak into the urine, low blood albumin, and swelling. This can lead to nephrotic syndrome.
Kidney involvement can be serious, but the outlook depends on the type of amyloidosis, the extent of organ damage, and how quickly treatment controls the underlying disease.
What Is Amyloidosis?
Proteins normally fold into shapes that allow them to perform their jobs. In amyloidosis, certain proteins fold abnormally and form deposits called amyloid.
These deposits can accumulate in organs such as the kidneys, heart, liver, and nerves. Over time, they can interfere with normal organ function.
The two important types affecting the kidneys are:
- AL amyloidosis: Caused by abnormal light-chain proteins produced by plasma cells, a type of immune cell in the bone marrow.
- AA amyloidosis: Develops when a protein called serum amyloid A remains elevated during prolonged inflammation, sometimes due to chronic inflammatory diseases or persistent infections.
The distinction matters because each type requires a different treatment approach.
How Amyloidosis Damages the Kidneys
The kidneys contain millions of tiny filtering units called nephrons. Each nephron includes a glomerulus, a small cluster of blood vessels that filters waste while normally keeping most blood proteins inside the bloodstream.
When amyloid deposits accumulate in the glomeruli and other kidney structures, they can disrupt this filtering barrier.
As a result:
- Protein leaks into the urine.
- Blood albumin levels may fall because albumin is lost through the kidneys.
- Fluid can accumulate in tissues, causing swelling.
- Kidney filtering capacity may decline as the disease progresses.
Amyloid deposits do not always affect the kidneys in the same way. Some people develop heavy protein loss before their kidney filtration rate falls significantly. Others develop declining kidney function with less obvious protein leakage.
What Is Nephrotic Syndrome?
Nephrotic syndrome is a collection of findings caused by excessive protein loss through the kidneys.
Its main features include:
- Heavy proteinuria: An unusually large amount of protein in the urine.
- Low blood albumin: Albumin is a protein that helps keep fluid inside blood vessels.
- Swelling (edema): Often noticeable around the eyes, ankles, legs, or abdomen.
- Increased risk of blood clots: Some people also have higher cholesterol levels.
Amyloidosis is one possible cause of nephrotic syndrome, but it is not the only one. Diabetes, certain immune diseases, and other kidney disorders can produce similar findings.
Foamy urine or swelling alone cannot confirm nephrotic syndrome or identify its cause.
How Is Kidney Amyloidosis Diagnosed?
Diagnosis usually combines urine tests, blood tests, kidney-function measurements, and sometimes a tissue biopsy.
1. Urine protein testing
A urine albumin-to-creatinine ratio (UACR), protein-to-creatinine ratio (UPCR), or 24-hour urine collection can help measure protein loss.
2. Blood tests
Blood albumin, creatinine, and estimated glomerular filtration rate (eGFR) help assess the effects on the body and kidney function. A normal or near-normal eGFR does not exclude significant kidney amyloidosis.
3. Testing for the underlying type
Blood and urine tests for abnormal monoclonal proteins, including serum free light chains when appropriate, can help investigate AL amyloidosis. Evaluation for persistent inflammation and serum amyloid A may be relevant when AA amyloidosis is suspected.
4. Kidney biopsy
A biopsy may be needed to confirm amyloid deposits and determine their type. Special staining and protein-typing methods help distinguish amyloidosis from other kidney diseases and guide treatment.
The exact diagnostic pathway depends on the clinical findings. No single blood or urine test can reliably establish every type of amyloidosis.
Can Kidney Amyloidosis Be Treated?
Yes. Treatment can slow or stop further amyloid accumulation in some patients, but established kidney damage may not fully reverse.
Treatment depends on the underlying type.
- AL amyloidosis: Treatment aims to control the abnormal plasma cells producing the harmful light chains. Specialist-directed therapies may include targeted medicines and other plasma-cell treatments.
- AA amyloidosis: Treatment focuses on controlling the chronic inflammation or infection driving serum amyloid A production.
- Kidney complications: Clinicians may also treat swelling, manage blood pressure, monitor kidney function, and address other complications.
Treatment decisions require specialist care, often involving a nephrologist and a hematologist or another physician experienced in amyloidosis.
What Should You Do Next?
If you have unexplained heavy urine protein, low blood albumin, persistent swelling, or declining kidney function, discuss the findings with a healthcare professional.
If amyloidosis has been diagnosed, useful questions include:
- Which type of amyloidosis do I have?
- Are my kidneys the only organs affected?
- How much protein am I losing in my urine?
- What is my current eGFR, and how has it changed?
- What treatment is available for my specific type?
- How will we monitor whether treatment is working?
Seek urgent medical attention for severe shortness of breath, chest pain, fainting, or sudden painful swelling in one leg, as these may indicate serious complications.
Bottom Line
Amyloidosis can damage the kidneys when misfolded proteins accumulate in their filtering structures. This may cause nephrotic syndrome, heavy protein loss, swelling, and declining kidney function.
The most important steps are to identify the exact type of amyloidosis, assess kidney involvement, and treat the underlying cause promptly. Early, appropriate treatment may protect remaining kidney function, although recovery depends on how much damage has already occurred.